相关实验视频

Updated: Jan 11, 2026

In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes

In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes

Published on: June 10, 2021

使用神经退行性疾病的iPSC模型进行药物发现研究

Masahiro Adachi¹, Haruhiko Banno², Haruhisa Inoue³

¹Graduate School of Medicine, Kyoto University, Kyoto, Japan; Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.

Neuroscience research

|November 10, 2025

概括

诱导多能干细胞 (iPSCs) 为药物发现提供了有价值的患者特异性疾病模型. 研究强调了iPSC在ALS和AD等神经退行性疾病中的应用,包括AI驱动的查和临床试验.

科学领域:

干细胞生物学干细胞生物学
神经科学是一个神经科学.
药理学药理学是指药理学的学科.

背景情况:

诱导多能干细胞 (iPSCs) 提供患者特异性疾病模型用于研究.
对于了解疾病机制和开发治疗方法,iPSC技术至关重要.
像ALS和AD这样的神经退行性疾病是iPSC应用的重要研究领域.

研究的目的:

对神经退行性疾病中iPSC应用的当前研究格局进行审查.
探索iPSC在研究疾病机制和药物发现中的应用.
要突出涉及iPSC的临床试验和AI集成查方法.

主要方法:

关于神经退行性疾病的iPSC研究现有文献的综述.
对基于iPSC的疾病建模对肌缩侧面硬化症 (ALS) 和阿尔茨海默病 (AD) 的分析.
检查使用iPSC的药物查策略和临床试验数据.

主要成果:

通过iPSC,可以创建基因匹配的疾病模型,从而推进机理学研究.
基于iPSC的查平台在识别新药候选药物方面表现有前途.
几项临床试验正在研究iPSC衍生疗法和用于ALS和相关疾病的药物重用.

结论:

iPSC技术是解开神经退行性疾病复杂性的强大工具.
将iPSC与人工智能的整合提高了药物发现效率.
持续的iPSC研究对于推进翻译医学和开发神经退行性疾病的有效治疗方法至关重要.

关键词:

阿尔茨海默氏症 (AD) 是一种疾病.肌缩侧面硬化/前性痴呆症 (ALS/FTD) 是一种疾病.肌缩侧面硬化症 (ALS) 是一种疾病.药物发现研究药物发现研究诱导多能干细胞 (iPSCs) 是一种干细胞.神经退行性疾病的神经退行性疾病

更多相关视频

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery

Published on: May 19, 2018

相关概念视频

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...